Home » Authors » Donna Young

Donna Young

Articles

ARTICLES

Sebelius Vows to Lead HHS with Science, Bipartisanship

April 3, 2009

FDA Panel Recommends Avastin for Brain Cancer

April 1, 2009

FDA: Avastin Data Unclear for Brain Cancer Approval

March 31, 2009

Kennedy Bill to Reignite 1970s War on Cancer

March 30, 2009

Tricky Endpoints Doom Neurocrine Pain Trial

March 27, 2009

NovaBay in $50M Skin Drug Deal with Galderma

March 26, 2009

Shares of NovaBay Pharmaceuticals Inc. rose 8.3 percent Wednesday after the Emeryville, Calif.-based firm said it inked a deal with Swiss firm Galderma SA to develop and commercialize antimicrobial compounds to treat acne and impetigo and other potential indications. (BioWorld Today)

Judge: FDA's Plan B Decision was Political, Not Safety-Related

March 25, 2009

Genome scan studies hold promise for cancer research

March 24, 2009

Appeals Court Sides with Feds on GSK Patent Case

March 24, 2009

HHS, IOM Take First Steps on Comparative Effectiveness

March 23, 2009

View All Articles by Donna Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...